For CIN tumors at early stage (Fig. 7a), the APC, KRAS, and TP53 mutations and arm-level copy losses occur one after another, and the dominant clones carry all of these driver alterations—so the linear model is in action at early stage. This evidence concerns the gene KRAS and cervical squamous intraepithelial neoplasia.